Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Over the years, many of our collaborators have brought us archived FFPE samples for next-generation sequencing. As a result, we have acquired a great deal of experience with sub-optimal FFPE samples and have developed and validated techniques that consistently
allow us to obtain high-quality data.
In addition to our standard suite of services, CCGD often takes part in collaborations to develop and evaluate new NGS assays and techniques. As part of this process, we work with investigators in forging a research and development proposal and can assist
in all aspects of research, including procurement of funding (e.g., grant submissions).
Liquid biopsies represent a readily accessible sample type upon which molecular profiling with NGS can be performed. CCGD has worked with several investigators to develop library construction methods tailored to the needs of cfDNA. We've recently replaced
our library adapters with unique, dual-matched barcode adapters containing a unique molecular identifier (UMI) which allow us to:
Current efforts are directed towards development of custom cfDNA hybrid capture gene panels.
We are currently refining our library prep protocol to use FFPE samples and will be designing custom hybrid capture bait sets that will target both messenger RNA and fusion transcripts resulting from genomic rearrangements:
CCGD: Aaron ThornerProfile: Elizabeth GarciaBioinformatics: Matthew Ducar
For general questions:617-582-7253 email@example.com